Literature DB >> 20123154

2-Arylthiomorpholine derivatives as potent and selective monoamine oxidase B inhibitors.

Susan Lühr1, Marcelo Vilches-Herrera, Angélica Fierro, Rona R Ramsay, Dale E Edmondson, Miguel Reyes-Parada, Bruce K Cassels, Patricio Iturriaga-Vásquez.   

Abstract

2-Arylthiomorpholine and 2-arylthiomorpholin-5-one derivatives, designed as rigid and/or non-basic phenylethylamine analogues, were evaluated as rat and human monoamine oxidase inhibitors. Molecular docking provided insight into the binding mode of these inhibitors and rationalized their different potencies. Making the phenylethylamine scaffold rigid by fixing the amine chain in an extended six-membered ring conformation increased MAO-B (but not MAO-A) inhibitory activity relative to the more flexible alpha-methylated derivative. The presence of a basic nitrogen atom is not a prerequisite in either MAO-A or MAO-B. The best K(i) values were in the 10(-8)M range, with selectivities towards human MAO-B exceeding 2000-fold. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20123154     DOI: 10.1016/j.bmc.2010.01.029

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

1.  Coumarin-Chalcone Hybrids as Inhibitors of MAO-B: Biological Activity and In Silico Studies.

Authors:  Guillermo Moya-Alvarado; Osvaldo Yañez; Nicole Morales; Angélica González-González; Carlos Areche; Marco Tulio Núñez; Angélica Fierro; Olimpo García-Beltrán
Journal:  Molecules       Date:  2021-04-22       Impact factor: 4.411

2.  3D-QSAR and in-silico Studies of Natural Products and Related Derivatives as Monoamine Oxidase Inhibitors.

Authors:  Priyanka Dhiman; Neelam Malik; Anurag Khatkar
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

3.  A Peroxidase-linked Spectrophotometric Assay for the Detection of Monoamine Oxidase Inhibitors.

Authors:  Kangkang Zhi; Zhongduo Yang; Jie Sheng; Zongmei Shu; Yin Shi
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.